Daniel Tabet on Impacts of Nearly All Possible Missense Variants in the FH Gene LDLR
Daniel Tabet, Postdoctoral Research Associate at Broad Institute of MIT and Harvard, shared on LinkedIn:
”Big news!
Last week, our new study measuring the functional impacts of nearly all possible (~17k) missense variants in the FH gene LDLR was published as a First Release in Science Magazine—check it out!
This work, many years in the making, came together thanks to the many incredible scientists I’ve had the privilege of working alongside.
I’m enormously grateful to my co-first author, Atina Cote, who drove the experimental work with amazing creativity, and of course to my PhD mentor, Fritz Roth, who guided us through this project with clarity and vision.
A big thank you as well to Megan Lancaster, who pulled off the analysis in All of Us; to the many cardiologists and members of the CardioVar team (Calum MacRae, Dan Roden, Robert Hegele, Joshua Knowles, Euan Ashley, and many others) for a wealth of thoughtful guidance; and to members of the Roth Lab (most especially Jochen Weile) who were instrumental to this project.
So proud of how this came together and humbled to be part of such an outstanding team!”
Read the full article in Science.
Article: The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR
Authors: Anna Axakova, Mafalda Bourbon, Jack M. P. Castelli, Victoria N. Parikh, Melina Claussnitzer, Atina G. Coté, Elizabeth T. Cirulli, Carmela Serio Carrero, Douglas M. Fowler, Iosifina Fotiadou, Michael Garton, Aanshi Gandhi, Andrew M. Glazer, Ranim Maaieh, Mohammad Majharul Islam, Kenneth Matreyek, Calum A. MacRae, Brett M. Kroncke, Da Kuang, Nishka Kishore, Joshua W. Knowles, Jennifer J. Knapp, Roujia Li, Megan C. Lancaster, Shahin Sowlati-Hashjin, Simon G. Pfisterer, Ashyad Rayhan, Dan M. Roden, Frederick P. Roth, Daniel Tabet, Olivia Taverniti, Jochen Weile, Euan A. Ashley, Robert A. Hegele

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy